Nu Skin Enterprises, Inc. (NUS) Stock Competitors & Peer Comparison

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, PG has a market cap of 327.8B. Regarding current trading prices, NUS is priced at $5.43, while PG trades at $147.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas PG's P/E ratio is 20.58. In terms of profitability, NUS's ROE is +0.07%, compared to PG's ROE of +0.31%. Regarding short-term risk, NUS is less volatile compared to PG. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check PG's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, UL has a market cap of 119.2B. Regarding current trading prices, NUS is priced at $5.43, while UL trades at $56.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas UL's P/E ratio is 18.23. In terms of profitability, NUS's ROE is +0.07%, compared to UL's ROE of +0.36%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, CL has a market cap of 68.1B. Regarding current trading prices, NUS is priced at $5.43, while CL trades at $88.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas CL's P/E ratio is 32.99. In terms of profitability, NUS's ROE is +0.07%, compared to CL's ROE of +4.75%. Regarding short-term risk, NUS is less volatile compared to CL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check CL's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, KVUE has a market cap of 32.4B. Regarding current trading prices, NUS is priced at $5.43, while KVUE trades at $17.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas KVUE's P/E ratio is 20.11. In terms of profitability, NUS's ROE is +0.07%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, NUS is less volatile compared to KVUE. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, KMB has a market cap of 31.4B. Regarding current trading prices, NUS is priced at $5.43, while KMB trades at $98.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas KMB's P/E ratio is 18.27. In terms of profitability, NUS's ROE is +0.07%, compared to KMB's ROE of +1.44%. Regarding short-term risk, NUS is less volatile compared to KMB. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check KMB's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, EL has a market cap of 30B. Regarding current trading prices, NUS is priced at $5.43, while EL trades at $83.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas EL's P/E ratio is -118.46. In terms of profitability, NUS's ROE is +0.07%, compared to EL's ROE of -0.06%. Regarding short-term risk, NUS is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EL's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, CHD has a market cap of 22.3B. Regarding current trading prices, NUS is priced at $5.43, while CHD trades at $97.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas CHD's P/E ratio is 30.96. In terms of profitability, NUS's ROE is +0.07%, compared to CHD's ROE of +0.17%. Regarding short-term risk, NUS is less volatile compared to CHD. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check CHD's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, SGI has a market cap of 14.6B. Regarding current trading prices, NUS is priced at $5.43, while SGI trades at $68.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas SGI's P/E ratio is 27.86. In terms of profitability, NUS's ROE is +0.07%, compared to SGI's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SGI's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, CLX has a market cap of 10.8B. Regarding current trading prices, NUS is priced at $5.43, while CLX trades at $93.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas CLX's P/E ratio is 14.57. In terms of profitability, NUS's ROE is +0.07%, compared to CLX's ROE of +28.26%. Regarding short-term risk, NUS is less volatile compared to CLX. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check CLX's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $5.43, while NTCO trades at $6.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is +0.07%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, ELF has a market cap of 3.1B. Regarding current trading prices, NUS is priced at $5.43, while ELF trades at $49.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas ELF's P/E ratio is 116.90. In terms of profitability, NUS's ROE is +0.07%, compared to ELF's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check ELF's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, IPAR has a market cap of 2.8B. Regarding current trading prices, NUS is priced at $5.43, while IPAR trades at $90.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas IPAR's P/E ratio is 16.87. In terms of profitability, NUS's ROE is +0.07%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, NUS is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, NUS is priced at $5.43, while SPB trades at $82.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas SPB's P/E ratio is 15.96. In terms of profitability, NUS's ROE is +0.07%, compared to SPB's ROE of +0.07%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, NWL has a market cap of 1.6B. Regarding current trading prices, NUS is priced at $5.43, while NWL trades at $3.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas NWL's P/E ratio is -5.73. In terms of profitability, NUS's ROE is +0.07%, compared to NWL's ROE of -0.11%. Regarding short-term risk, NUS is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check NWL's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, COTY has a market cap of 1.6B. Regarding current trading prices, NUS is priced at $5.43, while COTY trades at $1.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas COTY's P/E ratio is -2.97. In terms of profitability, NUS's ROE is +0.07%, compared to COTY's ROE of -0.15%. Regarding short-term risk, NUS is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check COTY's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, EPC has a market cap of 909.2M. Regarding current trading prices, NUS is priced at $5.43, while EPC trades at $20.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas EPC's P/E ratio is -85.78. In terms of profitability, NUS's ROE is +0.07%, compared to EPC's ROE of -0.05%. Regarding short-term risk, NUS is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EPC's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, HELE has a market cap of 582.1M. Regarding current trading prices, NUS is priced at $5.43, while HELE trades at $24.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas HELE's P/E ratio is -0.64. In terms of profitability, NUS's ROE is +0.07%, compared to HELE's ROE of -0.95%. Regarding short-term risk, NUS is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check HELE's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, NUS is priced at $5.43, while EWCZ trades at $5.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, NUS's ROE is +0.07%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, NUS is priced at $5.43, while PTNM trades at $10.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas PTNM's P/E ratio is 346.33. In terms of profitability, NUS's ROE is +0.07%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, NUS is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PTNM's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, ACU has a market cap of 169M. Regarding current trading prices, NUS is priced at $5.43, while ACU trades at $44.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas ACU's P/E ratio is 19.11. In terms of profitability, NUS's ROE is +0.07%, compared to ACU's ROE of +0.08%. Regarding short-term risk, NUS is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check ACU's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, SLSN has a market cap of 95M. Regarding current trading prices, NUS is priced at $5.43, while SLSN trades at $1.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas SLSN's P/E ratio is 134.50. In terms of profitability, NUS's ROE is +0.07%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, SKIN has a market cap of 79.1M. Regarding current trading prices, NUS is priced at $5.43, while SKIN trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas SKIN's P/E ratio is -4.69. In terms of profitability, NUS's ROE is +0.07%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, NUS is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SKIN's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, GROV has a market cap of 52.1M. Regarding current trading prices, NUS is priced at $5.43, while GROV trades at $1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas GROV's P/E ratio is -4.59. In terms of profitability, NUS's ROE is +0.07%, compared to GROV's ROE of -1.06%. Regarding short-term risk, NUS is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check GROV's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, AXIL has a market cap of 47.2M. Regarding current trading prices, NUS is priced at $5.43, while AXIL trades at $6.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas AXIL's P/E ratio is 57.67. In terms of profitability, NUS's ROE is +0.07%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check AXIL's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, UG has a market cap of 32.2M. Regarding current trading prices, NUS is priced at $5.43, while UG trades at $7.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas UG's P/E ratio is 13.48. In terms of profitability, NUS's ROE is +0.07%, compared to UG's ROE of +0.21%. Regarding short-term risk, NUS is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check UG's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, MTEX has a market cap of 10.8M. Regarding current trading prices, NUS is priced at $5.43, while MTEX trades at $5.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas MTEX's P/E ratio is -0.84. In terms of profitability, NUS's ROE is +0.07%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, NUS is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check MTEX's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, NUS is priced at $5.43, while PHH trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas PHH's P/E ratio is -0.53. In terms of profitability, NUS's ROE is +0.07%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, RAY has a market cap of 9.3M. Regarding current trading prices, NUS is priced at $5.43, while RAY trades at $3.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas RAY's P/E ratio is 4.20. In terms of profitability, NUS's ROE is +0.07%, compared to RAY's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check RAY's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, DSY has a market cap of 8.8M. Regarding current trading prices, NUS is priced at $5.43, while DSY trades at $1.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas DSY's P/E ratio is -0.21. In terms of profitability, NUS's ROE is +0.07%, compared to DSY's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check DSY's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $5.43, while BRSH trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is +0.07%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, TANH has a market cap of 2.6M. Regarding current trading prices, NUS is priced at $5.43, while TANH trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas TANH's P/E ratio is -0.03. In terms of profitability, NUS's ROE is +0.07%, compared to TANH's ROE of -0.25%. Regarding short-term risk, NUS is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TANH's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, DSYWW has a market cap of 1.1M. Regarding current trading prices, NUS is priced at $5.43, while DSYWW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas DSYWW's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check DSYWW's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, TKLF has a market cap of 800K. Regarding current trading prices, NUS is priced at $5.43, while TKLF trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas TKLF's P/E ratio is 1.72. In terms of profitability, NUS's ROE is +0.07%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, NUS is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TKLF's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $5.43, while BRSHW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, NUS is priced at $5.43, while RDEN trades at $13.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas RDEN's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, NUS is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check RDEN's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $5.43, while SUMR trades at $11.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is +0.07%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, NUS is priced at $5.43, while GROV-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, NUS is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check GROV-WT's competition here

NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUS stands at 258M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $5.43, while REV trades at $3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUS currently has a P/E ratio of 4.92, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is +0.07%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here